← Back to Clinical Trials
Recruiting NCT05009394

Surgical Treatments for Postamputation Pain

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Residual Limb Pain
Sponsor Prometei Pain Rehabilitation Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 110
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-06-20
Completion 2026-06
Interventions
Targeted Muscle Reinnervation (TMR)Regenerative Peripheral Nerve Interface (RPNI)Standard neuroma treatment, neuroma excision, and muscle burying

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a double-blind randomised controlled trial (RCT) which compares the effectiveness of three surgical techniques for alleviating residual limb pain (RLP), neuroma pain and phantom limb pain (PLP). The three surgical treatments are Targeted Muscles Reinnervation (TMR), Regenerative Peripheral Nerve Interface (RPNI), and an active control (neuroma excision and muscle burying). Patients will be follow-up for 4 years.

Eligibility Criteria

Inclusion Criteria: * The participant must have a major limb amputation. * The participant is ≥ 18 years old at the time of consent. * The participant must be in generally good health to undergo a surgical intervention, as per the clinical investigator's opinion. * Time since the last amputation must be over a year at the time of consent. * The participant must have an average residual limb pain score equal or greater than 4 on the Numerical Rating Scale (NRS, 0-10) after the baseline period. * If the participant has been prescribed pharmacological treatments for pain, there must be no variations in dosage (steady consumption) for at least 1 month before the screening visit. * If the participant has been prescribed non-pharmacological treatments for pain, such as spinal cord stimulation, transcutaneous electrical nerve stimulation, and mirror therapy, the treatment must have ended at least 1 month before the screening visit. * The participant must have a stable prosthetic fitting for a

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}